Aneurysm observation versus intervention: A literature review

Neurological Research

Volumn 24, Issue SUPPL. 1, 2002, Pages

  Connolly, P ^a   Biller, J ^a   Pritz, M B ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Incidence; Intracranial aneurysm; Prevalence; Screening; Subarachnoid hemorrhage

Indexed keywords

ANEURYSM; ANEURYSM RUPTURE; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; INTRACRANIAL ANEURYSM; MASS SCREENING; REVIEW; RISK FACTOR; SCREENING TEST; SUBARACHNOID HEMORRHAGE; TREATMENT PLANNING; COST BENEFIT ANALYSIS; ECONOMICS;

COST-BENEFIT ANALYSIS; HUMAN; INTRACRANIAL ANEURYSM; MASS SCREENING; SUBARACHNOID HEMORRHAGE; HUMANS;

EID: 0036286547     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Surgery for unruptured intracranial aneurysms
2. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage, Section V, Part II: Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations
3. Unruptured intracranial aneurysms. Risk of rupture and risks of surgical intervention
4. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage
5. Guglielmi detachable coil embolization of acute intracranial aneurysm: Peri-operative anatomical and clinical outcome in 403 patients
6. The natural history of unruptured intracranial aneurysms
7. Prevalence and risk of rupture of intracranial aneurysms: A systematic review
8. Risk of harboring an unruptured intracranial aneurysm
9. Autopsy study of unruptured incidental intracranial aneurysms
10. Asymptomatic cerebral aneurysm: Assessment of its risk of rupture
11. Aneurysms and anatomical variation of cerebral arteries
12. Berry aneurysms of the circle of Willis: Results of a planned autopsy study
13. The size of intracranial saccular aneurysms: An autopsy study
14. Natural history of unruptured intracranial aneurysms: A long-term follow-up study
15. Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985
16. Significance of unruptured intracranial saccular aneurysms
17. Treatment of unruptured cerebral aneurysms
18. Management of cerebral aneurysms: Further facts and additional myths
19. Incidence of subarachnoid hemorrhage: Role of region, year and rate of computed tomography: A meta-analysis
20. The detection and management of unruptured intracranial aneurysms
21. Are cerebral aneurysms atherosclerotic?
22. Risk factors for subarachnoid hemorrhage: A systematic review
23. Oral contraceptives and the risk of subarachnoid hemorrhage: A meta-analysis
24. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
25. The long-term outcome in patients with multiple aneurysms: Incidence of late hemorrhage and implications for treatment of incidental aneurysms
26. Management of the unruptured intracranial aneurysm (Editorial)
27. Health maintenance and the role of screening
28. Imaging of intracranial aneurysms and aubarachnoid hemorrhage
29. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
30. MR Angiography in neurologic disease
31. Familial subarachnoid hemorrhage in East Finland
32. Asymptomatic familial cerebral aneuryms
33. Should we screen for familial intracranial aneurysm?
34. Initial and follow up screening for aneurysms in families with familial subarachnoid hemorrhage
35. MR angiography as a screening tool for intracranial aneurysms: Feasibility, test characteristics and interobserver agreement
36. The kidney
37. Intracranial aneurysms in autosomal dominant polycystic kidney disease
38. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease
39. Recurrent rupture of intracranial aneurysms in autosomal dominant polycystic kidney disease
40. Recurrent intracranial aneurysms in autosomal dominant polycystic kidney disease
41. Patients with polycystic kidney disease would benefit for routine magnetic resonance angiographic screening for intracerebral aneurysms: A decision analysis
42. Marfan syndrome is not associated with intracranial aneurysms
43. Is Marfan syndrome associated with symptomatic intracranial aneurysms?
44. Cost-effectiveness analysis of screening for asymptomatic, unruptured intracranial aneurysms
45. Hospital resource utilization in the treatment of cerebral aneurysms
46. MR angiography and surgery for unruptured familial intracranial aneurysms in persons with a family history of cerebral aneurysms
47. Cost-effectiveness of screening unruptured cerebral aneurysms in Japan
48. Growth of small saccular aneurysms to giant aneurysms: Presentation of three cases
49. Recommendations for the management of patients with unruptured intracranial aneurysms: A statement for healthcare professionals for the Stroke Council of The American Heart Association
50. Management of incidental intracranial aneurysms
51. Surgical treatment of asymptomatic and incidental intracranial aneurysms
52. Surgical prognosis of unruptured intracranial arterial aneurysms
53. Clinical features and outcome in 48 patients with unruptured intracranial saccular aneurysms: A prospective consecutive study
54. The incidence and treatment of asymptomatic, unruptured cerebral aneurysms
55. Intracranial aneurysms: Size, risk of rupture and prophylactic surgical treatment
56. Electrothrombosis of saccular aneurysms via endovascular approach. Part 2: Preliminary clinical experience
57. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II Clinical aspects and recommendations
58. Endovascular treatment of unruptured aneurysms
59. Embolization of incidental cerebral aneurysms by using the Guglielmi detachable coil system
60. Guglielmi detachable coil embolization for unruptured aneurysms in nonsurgical candidates: A cost-effectiveness exploration
61. Functional outcome after repair of unruptured intracranial aneurysms
62. Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals
63. Decision Analysis
64. Decision analysis of the management of incidental intracranial saccular aneurysms
65. Treatment of intact intracranial aneurysms: A decision-analytical approach
66. Surgery of unruptured, asymptomatic aneurysms: A decision analysis
67. Effectiveness of preventive surgery for asymptomatic unruptured intracranial aneurysms
68. Management of unruptured intracranial aneurysm in Japan: A Markovian decision analysis with utility measurements based on the Glasgow outcome scale
69. Reanalysis of unruptured intracranial aneurysm management: Effect of a new international study on the threshold probabilities
70. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury
71. Endarterectomy for asymptomatic carotid artery stenosis
72. Elective surgery for asymptomatic, unruptured intracranial aneurysms: A cost-effectiveness analysis
73. Which unruptured cerebral aneuysms should be treated: A cost-utility analysis
74. Natural history of postoperative aneurysm rests